Company / Shareholders' Equity
BIOADAPTIVES, INC. Shareholders' Equity History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
-$2.1M
FY2025
5-year range
-$2.1M / -$1.1M
FY2021-FY2025
Trend
-45.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
BIOADAPTIVES, INC. reports negative total equity of -$2M in FY2025. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-$2M in FY2025.
Declined from -$2M to -$2M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, shareholders' equity decreased 45.5% year-over-year.
- Peak shareholders' equity was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score -61.64 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.1M | -45.5% |
| FY2024 | -$1.5M | +11.1% |
| FY2023 | -$1.6M | -13.4% |
| FY2022 | -$1.5M | -32.8% |
| FY2021 | -$1.1M | +20.7% |
| FY2020 | -$1.4M | -64.2% |
| FY2019 | -$839.9K | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026